Conservative hemodynamic surgery for varicose veins.

E. Criado,S. Luján,L. Izquierdo,E. Puras,M. Gutierrez,J. Fontcuberta

DOI: https://doi.org/10.1016/S0895-7967(02)70013-6

IF: 2.5

2002-03-01

Seminars in Vascular Surgery

Abstract:

What problem does this paper attempt to address?

Field evaluation of validity and feasibility of Pan-Lassa rapid diagnostic test for Lassa fever in Abakaliki, Nigeria: a prospective diagnostic accuracy study

Jelte Elsinga,Temmy Sunyoto,Letizia di Stefano,Pier Francesco Giorgetti,Htet Aung Kyi,Chiara Burzio,Ximena Campos Moreno,Chiedozie K Ojide,Nnennaya Ajayi,Richard Ewah,Emeka O Ogah,Chioma Dan-Nwafor,Anthony Ahumibe,Chinwe Lucia Ochu,Adebola Olayinka,Sylvie Jonckheere,Pascale Chaillet,Michel van Herp

DOI: https://doi.org/10.1016/s1473-3099(24)00184-1

IF: 71.421

2024-05-10

The Lancet Infectious Diseases

Abstract:Summary Background Lassa fever is a viral haemorrhagic fever with few options for diagnosis and treatment; it is also under-researched with knowledge gaps on its epidemiology. A point-of-care bedside test diagnosing Lassa fever, adhering to REASSURED criteria, is not currently available but is urgently needed in west African regions with high Lassa fever burden. We aimed to assess the validity and feasibility of a rapid diagnostic test (RDT) to confirm Lassa fever in people in Nigeria. Methods We estimated the diagnostic performance of the ReLASV Pan-Lassa RDT (Zalgen Labs, Frederick, MD, USA) as a research-use-only test, compared to RT-PCR as a reference standard, in 217 participants at a federal tertiary hospital in Abakaliki, Nigeria. We recruited participants between Feb 17, 2022, and April 17, 2023. The RDT was performed using capillary blood at the patient bedside and using plasma at the laboratory. The performance of the test, based on REASSURED criteria, was assessed for user friendliness, rapidity and robustness, sensitivity, and specificity. Findings Participants were aged between 0 and 85 years, with a median age of 33·0 years (IQR 22·0–44·3), and 24 participants were younger than 18 years. 107 (50%) participants were women and 109 (50%) were men; one participant had missing sex data. Although the specificity of the Pan-Lassa RDT was high (>90%), sensitivity at bedside using capillary blood was estimated as 4% (95% CI 1–14) at 15 min and 10% (3–22) at 25 min, far below the target of 90%. The laboratory-based RDT using plasma showed better sensitivity (46% [32–61] at 15 min and 50% [36–64] at 25 min) but did not reach the target sensitivity. Among the 52 PCR-positive participants with Lassa fever, positive RDT results were associated with lower cycle threshold values (glycoprotein precursor [GPC] gene mean 30·3 [SD 4·3], Large [L] gene mean 32·3 [3·7] vs GPC gene mean 24·5 [3·9], L gene mean 28·0 [3·6]). Personnel conducting the bedside test procedure reported being hindered by the inconvenient use of full personal protective equipment and long waiting procedures before a result could be read. Interpretation The Pan-Lassa RDT is not currently recommended as a diagnostic or screening tool for suspected Lassa fever cases. Marked improvement in sensitivity and user friendliness is needed for the RDT to be adopted clinically. There remains an urgent need for better Lassa fever diagnostics to promote safety of in-hospital care and better disease outcomes in low-resource settings. Funding Médecins Sans Frontières.

infectious diseases
Lassa fever in Nigeria: epidemiology and risk perception

Ahmad I Al-Mustapha,Ibukun Modupe Adesiyan,Terese Gabriel Orum,Oluwaseun A. Ogundijo,Adedeji Nurudeen Lawal,Okechi E. Nzedibe,Libby O. Onyeka,Kabiru U Muhammad,Lateefah Odetayo,Muftau Oyewo,Shuaibu Osu Muhammad,Everest O. Atadiose,L Icomiare Adebudo,D Adeolu Adetunji,Hamman Joseph Jantiku,Alexander O. Akintule,Raymond C Nwachukwu,Ahmed Tijani Abubakar

DOI: https://doi.org/10.1038/s41598-024-78726-3

IF: 4.6

2024-11-18

Scientific Reports

Abstract:Annual outbreaks of Lassa fever have resulted in a public health threat in Nigeria and other endemic countries in Sub-Saharan Africa. While the Lassa Virus (LASV) is endemic in rodent populations, zoonotic spillover to humans causes annual outbreaks. This study reviewed the burden of Lassa fever (LF) in Nigeria between 2020 and 2023 and conducted a cross-sectional survey of Nigerians to evaluate their risk perceptions of LF. During the period under review, 28,780 suspected and 4,036 confirmed cases of LF were reported from 34 of the 37 states of Nigeria. These cases resulted in 762 deaths (a CFR of 18.9%). The overall case positivity rate was 14% (4,036/28,780), with more positive cases in 2020 (17.5%, n = 1,189/6,791). A total of 2,150 study participants were enrolled in the prospective cross-sectional study, with most of them (87.5%, n = 1,881/2,150) having previously heard of Lassa fever (LF). The numerical scoring system revealed that 35.43% ( n = 762/1,881) of those aware of LF have poor knowledge of its preventive measures, route of transmission, and control measures. Approximately 6.84% ( n = 147/2,150) of them were at a high risk of contracting LF, with 27.6% ( n = 584/2,150) of study participants feeling concerned about contracting LF because of the presence of rodents in their immediate vicinity, occupational exposure to healthcare workers, and the probability of contamination of food by infected rodents without necessary food safety measures. Multivariable logistic regression analysis revealed that tertiary education was associated with an increased likelihood of better LF knowledge (OR: 17.32; 95% CI: 10.62, 28.26; p < 0.01) and a lower risk of contracting LF when compared to respondents with no formal education. In addition, study participants who reside in low-burden states have lower LF perception than those residents in high-LF-burden states (OR: 0.59; 95% CI: 0.38–0.91; p = 0.049). On the other hand, study participants with poor risk perception (knowledge) of LF had a higher likelihood (RR: 0.33; 95% CI: 0.20, 0.53; p < 0.01) of contracting LF when compared to those with good knowledge of LF. Similarly, those residents in low LF burden states were less likely (OR: 0.09; 95% CI: 0.05,0.17; p < 0.01) to contract LF when compared to those residents in high burden states. There is a need to improve LF diagnostics capacity, infection prevention and control measures, and implementation of the One Health approach to controlling LASV from animal reservoirs. In addition, public enlightenment campaigns to address fundamental knowledge gaps are crucial to mitigating the ongoing and future impact of LF in Nigeria.

multidisciplinary sciences
Seroprevalence and risk factors for Lassa virus infection in South-West and North-Central Nigeria: a community-based cross-sectional study

Abdulwasiu B. Tiamiyu,Olutunde A. Adegbite,Olivia Freides,Seth Frndak,Samirah Sani Mohammed,Erica Broach,Kara Lombardi,Victor Anyebe,Roseline Akiga,Ndubuisi C. Okeke,Jegede E. Feyisayo,Oscar Ugwuezumba,Cassandra Akinde,Anthonia Osuji,Norah Agu,Tope Analogbei,Chinelo Ekweremadu,Danielle Bartolanzo,Petra Prins,Ying Fan,Doris Emekaili,Felicia Abah,Vincent Chiwetelu,Paul Dike,Esther Isaiah,Miriam Ayogu,Eunice Ogunkelu,Uzoamaka C. Agbaim,Adelekun Bukunmi,Yakubu Adamu,Tsedal Mebrahtu,Anastasia Zuppe,Matthew Johnston,Kayvon Modjarrad,Helina Meri,Zahra Parker,Edward Akinwale,Melanie D. McCauley,Glenna Schluck,David B. King,Leigh Anne Eller,Nathan Okeji,Ojor R. Ayemoba,Natalie D. Collins,Michael O. Iroezindu,Shilpa Hakre,EID023 Lassa study team,Adefunke Oladipo-Opashina,Alexus Reynolds,Austin Anikwe,Bahar Dastgheib,Blessing I. Wilson,Bryce Boron,Bwalya Chama,Daniel Choi,Edward Bloom,Ekenedirichukwu Okoli,Gereme Bandong,Helen Nwandu,Igiri Faith,Jenny Lay,Jumoke T. Nwalozie,Lawrence C. Umeji,Mekdi Taddese,Mihret Amare,Michelle Imbach,Nkiru Nnadi,Oyerinde Olunsanya,Sunday Odeyemi,Susan T. Mason,Zubairu Elayo

DOI: https://doi.org/10.1186/s12879-024-09954-1

IF: 3.7

2024-10-09

BMC Infectious Diseases

Abstract:Understanding the level of exposure to Lassa virus (LASV) in at-risk communities allows for the administration of effective preventive interventions to mitigate epidemics of Lassa fever. We assessed the seroprevalence of LASV antibodies in rural and semiurban communities of two cosmopolitan cities in Nigeria with poorly understood Lassa epidemiology.

infectious diseases
Differential pathogenesis of closely related 2018 Nigerian outbreak clade III Lassa virus isolates

Derek R. Stein,Bryce M. Warner,Jonathan Audet,Geoff Soule,Vinayakumar Siragam,Patrycja Sroga,Bryan D. Griffin,Anders Leung,Allen Grolla,Kevin Tierney,Alix Albietz,Darwyn Kobasa,Abdulmajid S. Musa,Adama Ahmad,Afolabi M. Akinpelu,Nwando Mba,Rebecca Rosenke,Dana P. Scott,Greg Saturday,Chikwe Ihekweazu,David Safronetz

DOI: https://doi.org/10.1371/journal.ppat.1009966

IF: 7.464

2021-10-11

PLoS Pathogens

Abstract:Nigeria continues to experience ever increasing annual outbreaks of Lassa fever (LF). The World Health Organization has recently declared Lassa virus (LASV) as a priority pathogen for accelerated research leading to a renewed international effort to develop relevant animal models of disease and effective countermeasures to reduce LF morbidity and mortality in endemic West African countries. A limiting factor in evaluating medical countermeasures against LF is a lack of well characterized animal models outside of those based on infection with LASV strain Josiah originating form Sierra Leone, circa 1976. Here we genetically characterize five recent LASV isolates collected from the 2018 outbreak in Nigeria. Three isolates were further evaluated in vivo and despite being closely related and from the same spatial / geographic region of Nigeria, only one of the three isolates proved lethal in strain 13 guinea pigs and non-human primates (NHP). Additionally, this isolate exhibited atypical pathogenesis characteristics in the NHP model, most notably respiratory failure, not commonly described in hemorrhagic cases of LF. These results suggest that there is considerable phenotypic heterogeneity in LASV infections in Nigeria, which leads to a multitude of pathogenesis characteristics that could account for differences between subclinical and lethal LF infections. Most importantly, the development of disease models using currently circulating LASV strains in West Africa are critical for the evaluation of potential vaccines and medical countermeasures.

microbiology,virology,parasitology
MARINE ZOOLOGY IN THE HAWAIIAN ISLANDS.

J. E. Duerden

DOI: https://doi.org/10.1126/SCIENCE.21.545.897

IF: 56.9

1905-06-09

Science

Abstract:
Factors associated with delayed presentation to healthcare facilities for Lassa fever cases, Nigeria 2019: a retrospective cohort study

Nastassya L Chandra,Hikaru Bolt,Chioma Dan-Nwafor,Oladipupo Ipadeola,Elsie Ilori,Geoffrey Namara,Adebola T Olayinka,Winifred Ukponu,Akanimo Iniobong,Michael Amedu,Adejoke Akano,Kachikwulu O Akabike,Uwaifiokun Okhuarobo,Stephen Fagbemi,Emeka Sampson,Sophie Newitt,Neville Q Verlander,Daniel G Bausch,Olivier le Polain de Waroux,Chikwe Ihekweazu

DOI: https://doi.org/10.1186/s12879-021-05822-4

2021-02-04

Abstract:Background: Large outbreaks of Lassa fever (LF) occur annually in Nigeria. The case fatality rate among hospitalised cases is ~ 20%. The antiviral drug ribavirin along with supportive care and rehydration are the recommended treatments but must be administered early (within 6 days of symptom onset) for optimal results. We aimed to identify factors associated with late presentation of LF cases to a healthcare facility to inform interventions. Methods: We undertook a retrospective cohort study of all laboratory confirmed LF cases reported in Nigeria from December 2018 to April 2019. We performed descriptive epidemiology and a univariate Cox proportional-hazards regression analysis to investigate the effect of clinical (symptom severity), epidemiological (age, sex, education, occupation, residential State) and exposure (travel, attendance at funeral, exposure to rodents or confirmed case) factors on time to presentation. Results: Of 389 cases, median presentation time was 6 days (IQR 4-10 days), with 53% attending within 6 days. There were no differences in presentation times by sex but differences were noted by age-group; 60+ year-olds had the longest delays while 13-17 year-olds had the shortest. By sex and age, there were differences seen among the younger ages, with 0-4-year-old females presenting earlier than males (4 days and 73% vs. 10 days and 30%). For 5-12 and 13-17 year-olds, males presented sooner than females (males: 5 days, 65% and 3 days, 85% vs. females: 6 days, 50% and 5 days, 61%, respectively). Presentation times differed across occupations 4.5-9 days and 20-60%, transporters (people who drive informal public transport vehicles) had the longest delays. Other data were limited (41-95% missing). However, the Cox regression showed no factors were statistically associated with longer presentation time. Conclusions: Whilst we observed important differences in presentation delays across factors, our sample size was insufficient to show any statistically significant differences that might exist. However, almost half of cases presented after 6 days of onset, highlighting the need for more accurate and complete surveillance data to determine if there is a systemic or specific cause for delays, so to inform, monitor and evaluate public health strategies and improve outcomes.
Ultrasound guided lithotripsy of salivary calculi using an electromagnetic lithotriptor.

Georg Eggers,R. Chilla

DOI: https://doi.org/10.1016/J.IJOM.2005.04.012

2005-12-01

Abstract:
Association of &bgr;-catenin with P-Smad3 but not LEF-1 dissociates in vitro profibrotic from anti-inflammatory effects of TGF-&bgr;1

X. Tian,Jianlin Zhang,Jianlin Zhang,T. K. Tan,J. Lyons,Hong Zhao,Hong Zhao,B. Niu,S. R. Lee,T. Tsatralis,Ye Zhao,Ya Wang,Q. Cao,Changqi Wang,Yiping Wang

DOI: https://doi.org/10.1242/jcs.103036

IF: 5.235

2013-01-01

Journal of Cell Science

Abstract:Summary Transforming growth factor &bgr;1 (TGF-&bgr;1) is known to be both anti-inflammatory and profibrotic. Cross-talk between TGF-&bgr;/Smad and Wnt/&bgr;-catenin pathways in epithelial–mesenchymal transition (EMT) suggests a specific role for &bgr;-catenin in profibrotic effects of TGF-&bgr;1. However, no such mechanistic role has been demonstrated for &bgr;-catenin in the anti-inflammatory effects of TGF-&bgr;1. In the present study, we explored the role of &bgr;-catenin in the profibrotic and anti-inflammatory effects of TGF-&bgr;1 by using a cytosolic, but not membrane, &bgr;-catenin knockdown chimera (F-TrCP-Ecad) and the &bgr;-catenin/CBP inhibitor ICG-001. TGF-&bgr;1 induced nuclear Smad3/&bgr;-catenin complex, but not &bgr;-catenin/LEF-1 complex or TOP-flash activity, during EMT of C1.1 (renal tubular epithelial) cells. F-TrCP-Ecad selectively degraded TGF-&bgr;1-induced cytoplasmic &bgr;-catenin and blocked EMT of C1.1 cells. Both F-TrCP-Ecad and ICG-001 blocked TGF-&bgr;1-induced Smad3/&bgr;-catenin and Smad reporter activity in C1.1 cells, suggesting that TGF-&bgr;1-induced EMT depends on &bgr;-catenin binding to Smad3, but not LEF-1 downstream of Smad3, through canonical Wnt. In contrast, in J774 macrophages, the &bgr;-catenin level was low and was not changed by interferon-&ggr; (IFN-&ggr;) or lipopolysaccharide (LPS) with or without TGF-&bgr;1. TGF-&bgr;1 inhibition of LPS-induced TNF-&agr; and IFN-&ggr;-stimulated inducible NO synthase (iNOS) expression was not affected by F-TrCP-Ecad, ICG-001 or by overexpression of wild-type &bgr;-catenin in J774 cells. Inhibition of &bgr;-catenin by either F-TrCP-Ecad or ICG-001 abolished LiCl-induced TOP-flash, but not TGF-&bgr;1-induced Smad reporter, activity in J774 cells. These results demonstrate for the first time that &bgr;-catenin is required as a co-factor of Smad in TGF-&bgr;1-induced EMT of C1.1 epithelial cells, but not in TGF-&bgr;1 inhibition of macrophage activation. Targeting &bgr;-catenin may dissociate the TGF-&bgr;1 profibrotic and anti-inflammatory effects.
Incorporating phosphorus cycling into global modeling efforts: a worthwhile, tractable endeavor.

S. Reed,Xiaojuan Yang,P. Thornton

DOI: https://doi.org/10.1111/nph.13521

IF: 9.4

2015-10-01

New Phytologist

Abstract:324 I. 324 II. 325 III. 326 IV. 327 328 References 328 SUMMARY: Myriad field, laboratory, and modeling studies show that nutrient availability plays a fundamental role in regulating CO2 exchange between the Earth's biosphere and atmosphere, and in determining how carbon pools and fluxes respond to climatic change. Accordingly, global models that incorporate coupled climate-carbon cycle feedbacks made a significant advance with the introduction of a prognostic nitrogen cycle. Here we propose that incorporating phosphorus cycling represents an important next step in coupled climate-carbon cycling model development, particularly for lowland tropical forests where phosphorus availability is often presumed to limit primary production. We highlight challenges to including phosphorus in modeling efforts and provide suggestions for how to move forward.
Metagenomic surveillance uncovers diverse and novel viral taxa in febrile patients from Nigeria

Judith U Oguzie,Brittany A Petros,Paul E Oluniyi,Samar B Mehta,Philomena E Eromon,Parvathy Nair,Opeoluwa Adewale-Fasoro,Peace Damilola Ifoga,Ikponmwosa Odia,Andrzej Pastusiak,Otitoola Shobi Gbemisola,John Oke Aiyepada,Eghosasere Anthonia Uyigue,Akhilomen Patience Edamhande,Osiemi Blessing,Michael Airende,Christopher Tomkins-Tinch,James Qu,Liam Stenson,Stephen F Schaffner,Nicholas Oyejide,Nnenna A Ajayi,Kingsley Ojide,Onwe Ogah,Chukwuyem Abejegah,Nelson Adedosu,Oluwafemi Ayodeji,Ahmed A Liasu,Sylvanus Okogbenin,Peter O Okokhere,Daniel J Park,Onikepe A Folarin,Isaac Komolafe,Chikwe Ihekweazu,Simon D W Frost,Ethan K Jackson,Katherine J Siddle,Pardis C Sabeti,Christian T Happi

DOI: https://doi.org/10.1038/s41467-023-40247-4

2023-08-04

Abstract:Effective infectious disease surveillance in high-risk regions is critical for clinical care and pandemic preemption; however, few clinical diagnostics are available for the wide range of potential human pathogens. Here, we conduct unbiased metagenomic sequencing of 593 samples from febrile Nigerian patients collected in three settings: i) population-level surveillance of individuals presenting with symptoms consistent with Lassa Fever (LF); ii) real-time investigations of outbreaks with suspected infectious etiologies; and iii) undiagnosed clinically challenging cases. We identify 13 distinct viruses, including the second and third documented cases of human blood-associated dicistrovirus, and a highly divergent, unclassified dicistrovirus that we name human blood-associated dicistrovirus 2. We show that pegivirus C is a common co-infection in individuals with LF and is associated with lower Lassa viral loads and favorable outcomes. We help uncover the causes of three outbreaks as yellow fever virus, monkeypox virus, and a noninfectious cause, the latter ultimately determined to be pesticide poisoning. We demonstrate that a local, Nigerian-driven metagenomics response to complex public health scenarios generates accurate, real-time differential diagnoses, yielding insights that inform policy.
Comparative Evaluation of Standard RT-PCR Assays and Commercial Real-Time RT-PCR Kits for Detection of Lassa Virus

Xue-Lian Luo,Xiu-Dan Zhang,Bei-Jie Li,Tian Qin,Zhi-Jie Cao,Qian-Jin Fan,Jing Yang,Dong Jin,Shan Lu,Ya-Yun Zheng,Xue-Fang Xu,Ji Pu,Jianguo Xu

DOI: https://doi.org/10.1128/spectrum.05011-22

IF: 3.7

2023-04-13

Microbiology Spectrum

Abstract:Lassa virus (LASV) is a significant human pathogen causing hemorrhagic fever in West Africa. Increased traveling around the world raises the risk of imported cases to other countries.

microbiology
Evaluation of Three Clinical Prediction Tools to Predict Mortality in Hospitalized Patients with Lassa Fever

John J Chiosi,John S Schieffelin,Jeffrey G Shaffer,Donald S Grant

DOI: https://doi.org/10.4269/ajtmh.20-1624

2022-06-27

Abstract:Lassa fever is a viral hemorrhagic illness with a case fatality rate for hospitalized patients as high as 69%. Identifying cases before they progress to serious illness can lead to earlier treatment and improved clinical outcomes. Three existing clinical prediction tools were evaluated on their ability to predict the in-hospital mortality in Lassa fever: the quick Sequential Organ Failure Assessment (qSOFA), the Modified Early Warning System (MEWS), and the Universal Vital Assessment (UVA). This was a retrospective cohort study of patients admitted to the dedicated Lassa fever ward of the Kenema Government Hospital in Sierra Leone between May 2013 and December 2019. Data among three serology groups were analyzed: Lassa antigen-positive (Ag+) regardless of IgM status, Lassa Ag- and IgM+, and Lassa Ag- and IgM- cases. There were 123 cases of suspected Lassa fever included in this study. Abnormalities in respiratory rate, oxygenation status, mental status, and serum markers of kidney and liver dysfunction were more likely seen in the Ag+ group, which had an in-hospital mortality of 85.7%. For the Lassa Ag+ group, the sensitivity and positive predictive value of qSOFA ≥ 2 was 70.6% and 92.3%, MEWS ≥ 5 was 96.9% and 86.1%, and UVA ≥ 5 was 60.0% and 100.0%. The MEWS and UVA scores show potential for use in Lassa fever, but there is opportunity for future development of a tool that includes the clinical and laboratory markers specific to Lassa fever.
Genome-wide association study identifies human genetic variants associated with fatal outcome from Lassa fever

Dylan Kotliar,Siddharth Raju,Shervin Tabrizi,Ikponmwosa Odia,Augustine Goba,Mambu Momoh,John Demby Sandi,Parvathy Nair,Eric Phelan,Ridhi Tariyal,Philomena E. Eromon,Samar Mehta,Refugio Robles-Sikisaka,Katherine J. Siddle,Matt Stremlau,Simbirie Jalloh,Stephen K. Gire,Sarah Winnicki,Bridget Chak,Stephen F. Schaffner,Matthias Pauthner,Elinor K. Karlsson,Sarah R. Chapin,Sharon G. Kennedy,Luis M. Branco,Lansana Kanneh,Joseph J. Vitti,Nisha Broodie,Adrianne Gladden-Young,Omowunmi Omoniwa,Pan-Pan Jiang,Nathan Yozwiak,Shannon Heuklom,Lina M. Moses,George O. Akpede,Danny A. Asogun,Kathleen Rubins,Susan Kales,Anise N. Happi,Christopher O. Iruolagbe,Mercy Dic-Ijiewere,Kelly Iraoyah,Omoregie O. Osazuwa,Alexander K. Okonkwo,Stefan Kunz,Joseph B. McCormick,S. Humarr Khan,Anna N. Honko,Eric S. Lander,Michael B. A. Oldstone,Lisa Hensley,Onikepe A. Folarin,Sylvanus A. Okogbenin,Stephan Günther,Hanna M. Ollila,Ryan Tewhey,Peter O. Okokhere,John S. Schieffelin,Kristian G. Andersen,Steven K. Reilly,Donald S. Grant,Robert F. Garry,Kayla G. Barnes,Christian T. Happi,Pardis C. Sabeti

DOI: https://doi.org/10.1038/s41564-023-01589-3

IF: 28.3

2024-02-08

Nature Microbiology

Abstract:Infection with Lassa virus (LASV) can cause Lassa fever, a haemorrhagic illness with an estimated fatality rate of 29.7%, but causes no or mild symptoms in many individuals. Here, to investigate whether human genetic variation underlies the heterogeneity of LASV infection, we carried out genome-wide association studies (GWAS) as well as seroprevalence surveys, human leukocyte antigen typing and high-throughput variant functional characterization assays. We analysed Lassa fever susceptibility and fatal outcomes in 533 cases of Lassa fever and 1,986 population controls recruited over a 7 year period in Nigeria and Sierra Leone. We detected genome-wide significant variant associations with Lassa fever fatal outcomes near GRM7 and LIF in the Nigerian cohort. We also show that a haplotype bearing signatures of positive selection and overlapping LARGE1 , a required LASV entry factor, is associated with decreased risk of Lassa fever in the Nigerian cohort but not in the Sierra Leone cohort. Overall, we identified variants and genes that may impact the risk of severe Lassa fever, demonstrating how GWAS can provide insight into viral pathogenesis.

microbiology
Health and economic impacts of Lassa vaccination campaigns in West Africa

David R. M. Smith,Joanne Turner,Patrick Fahr,Lauren A. Attfield,Paul R. Bessell,Christl A. Donnelly,Rory Gibb,Kate E. Jones,David W. Redding,Danny Asogun,Oladele Oluwafemi Ayodeji,Benedict N. Azuogu,William A. Fischer II,Kamji Jan,Adebola T. Olayinka,David A. Wohl,Andrew A. Torkelson,Katelyn A. Dinkel,Emily J. Nixon,Koen B. Pouwels,T. Déirdre Hollingsworth

DOI: https://doi.org/10.1038/s41591-024-03232-y

IF: 82.9

2024-08-30

Nature Medicine

Abstract:Lassa fever is a zoonotic disease identified by the World Health Organization (WHO) as having pandemic potential. This study estimates the health-economic burden of Lassa fever throughout West Africa and projects impacts of a series of vaccination campaigns. We also model the emergence of 'Lassa-X'—a hypothetical pandemic Lassa virus variant—and project impacts of achieving 100 Days Mission vaccination targets. Our model predicted 2.7 million (95% uncertainty interval: 2.1–3.4 million) Lassa virus infections annually, resulting over 10 years in 2.0 million (793,800–3.9 million) disability-adjusted life years (DALYs). The most effective vaccination strategy was a population-wide preventive campaign primarily targeting WHO-classified 'endemic' districts. Under conservative vaccine efficacy assumptions, this campaign averted 8.2– 128.2 million ( 231.9 million) in societal costs (2021 international dollars ($)). Reactive vaccination in response to local outbreaks averted just one-tenth the health-economic burden of preventive campaigns. In the event of Lassa-X emerging, spreading throughout West Africa and causing approximately 1.2 million DALYs within 2 years, 100 Days Mission vaccination averted 22% of DALYs given a vaccine 70% effective against disease and 74% of DALYs given a vaccine 70% effective against both infection and disease. These findings suggest how vaccination could alleviate Lassa fever's burden and assist in pandemic preparedness.

biochemistry & molecular biology,cell biology,medicine, research & experimental
Machine Learning Reveals Key Glycoprotein Mutations and Rapidly Assigns Lassa Virus Lineages

Richard Olumide Daodu,Jens-Uwe Ulrich,Denise Kuehnert

DOI: https://doi.org/10.1101/2024.07.31.605963

2024-11-05

Abstract:Lassa fever, caused by the Lassa virus (LASV), remains a major public health concern in West Africa, causing numerous fatalities annually and several intercontinental cases since its discovery in 1969. Despite ongoing research, no approved vaccines are available, with current efforts focusing on immunotherapy. LASV is divided into distinct lineages that circulate in specific geographic regions, elicit varying immune responses, and exhibit different pathophysiological effects. Understanding the genetic differences between these lineages is crucial for developing, improving, and distributing diagnostics, treatments, and vaccines. In this study, we analyzed the LASV glycoprotein complex (GPC), the only surface protein, using statistics, machine learning, and phylogenetics. At a population scale, we identified key amino acid differences between Nigerian lineages and those in other West African regions, particularly near the stable signal peptide cleavage site and other immune-related regions (e.g., AA positions 59-76). Additionally, we found that GPC sequences from Lineages II and III are shorter than those from Lineage IV, due to the high prevalence of a codon insertion at positions 178-180 (amino acid position 60). This insertion may contribute to inaccuracies observed in molecular diagnostics for LASV and may also play a role in the increased fatality associated with Lineage IV. The insertion has reemerged and persisted in Lineage II which may indicate a fitness advantage. Furthermore, we developed a fast and highly accurate lineage classification tool called CLASV that allows rapid identification of LASV lineages, improving the ability to monitor emerging outbreaks and exported cases.

Bioinformatics
The Importance of Lassa Fever and Its Disease Management in West Africa

Rachel A. Reyna,Kirsten E. Littlefield,Nathan Shehu,Tomoko Makishima,Junki Maruyama,Slobodan Paessler

DOI: https://doi.org/10.3390/v16020266

2024-02-08

Viruses

Abstract:Lassa virus (LASV) is a zoonotic pathogen endemic throughout western Africa and is responsible for a human disease known as Lassa fever (LF). Historically, LASV has been emphasized as one of the greatest public health threats in West Africa, with up to 300,000 cases and 5000 associated deaths per year. This, and the fact that the disease has been reported in travelers, has driven a rapid production of various vaccine candidates. Several of these vaccines are currently in clinical development, despite limitations in understanding the immune response to infection. Alarmingly, the host immune response has been implicated in the induction of sensorineural hearing loss in LF survivors, legitimately raising safety questions about any future vaccines as well as efficacy in preventing potential hearing loss. The objective of this article is to revisit the importance and prevalence of LF in West Africa, with focus on Nigeria, and discuss current therapeutic approaches and ongoing vaccine development. In addition, we aim to emphasize the need for more scientific studies relating to LF-associated hearing loss, and to promote critical discussion about potential risks and benefits of vaccinating the population in endemic regions of West Africa.

virology
An Assessment of Rainfall and Temperature on Seasonal Outbreak of Lassa Fever in Nigeria for the Year 2020

Kevin Barnabas Ndayakalah,Williams J.J.,Wushiya Joseph Gwade

DOI: https://doi.org/10.47772/ijriss.2022.6427

2022-01-01

International Journal of Research and Innovation in Social Science

Abstract:The present study examined the impacts of rainfall and temperature on the seasonal outbreak of Lassa fever in Nigeria for the year 2020. The sample size was based on cluster sampling of the seven states with the highest number of cases in 2020. Three states from the south and four states from the north. Suspected and confirmed cases were gathered from the week by week epidemiological report of the NCDC website from December 30, 2019/week 52 to June 28, 2020/week 26. Average rainfall and temperature data for each state were gathered on a weekly average basis from the weather records of AccuWeather.com. The findings showed that there were no significant relationships between the climatic variables and the number of suspected and confirmed cases. However, there were weak significant relationships between the number of deaths and average low temperature (r = – 0.24) and average temperature difference (r = 0.19). In the southern states, for every one-degree (1°F) increase in temperature (f), there are an additional 12.1, 5.6 and 1.7 suspected cases in Edo, Ondo and Ebonyi states. Average high temperature alone could explain ~50% of the increase in cases. Relationships were less clear in the northern states. In contrast to previous research, the study found that there is a non-linear relationship between the climatic variables and Lassa fever outbreaks
Lassa fever research priorities: towards effective medical countermeasures by the end of the decade

Kristine A Moore,Julia T Ostrowsky,Angela J Mehr,Rebecca A Johnson,Angela K Ulrich,Nicolina M Moua,Petra C Fay,Peter J Hart,Josephine P Golding,Virginia Benassi,Marie-Pierre Preziosi,Ifedayo M Adetifa,George O Akpede,William K Ampofo,Danny A Asogun,Alan D T Barrett,Daniel G Bausch,Ilse de Coster,Devy M Emperador,Heinz Feldmann,Elisabeth Fichet-Calvet,Pierre B H Formenty,Robert F Garry,Donald S Grant,Stephan Günther,Swati B Gupta,Marie Jaspard,Laura T Mazzola,Sylvanus A Okogbenin,Cathy Roth,Connie S Schmaljohn,Michael T Osterholm

DOI: https://doi.org/10.1016/S1473-3099(24)00229-9

Abstract:In 2016, WHO designated Lassa fever a priority disease for epidemic preparedness as part of the WHO Blueprint for Action to Prevent Epidemics. One aspect of preparedness is to promote development of effective medical countermeasures (ie, diagnostics, therapeutics, and vaccines) against Lassa fever. Diagnostic testing for Lassa fever has important limitations and key advancements are needed to ensure rapid and accurate diagnosis. Additionally, the only treatment available for Lassa fever is ribavirin, but controversy exists regarding its effectiveness. Finally, no licensed vaccines are available for the prevention and control of Lassa fever. Ongoing epidemiological and behavioural studies are also crucial in providing actionable information for medical countermeasure development, use, and effectiveness in preventing and treating Lassa fever. This Personal View provides current research priorities for development of Lassa fever medical countermeasures based on literature published primarily in the last 5 years and consensus opinion of 20 subject matter experts with broad experience in public health or the development of diagnostics, therapeutics, and vaccines for Lassa fever. These priorities provide an important framework to ensure that Lassa fever medical countermeasures are developed and readily available for use in endemic and at-risk areas by the end of the decade.
Highly-oxidised, sulfur-rich, mixed-valence vanadium(IV/V) complexes.

Michelle Taylor,David J Evans,C. G. Young

DOI: https://doi.org/10.1039/B610036H

IF: 4.9

2006-10-09

Chemical Communications

Abstract:The reactions of [V(2)(micro-S(2))(2)(S(2)CNR(2))(4)] (R = alkyl) with NOBF(4) produce highly-oxidised, sulfur-rich, V(iv/v) complexes, [V(2)(micro-S(2))(2)(S(2)CNR(2))(4)]BF(4), that exhibit 15-line EPR spectra and structures consistent with Class III mixed-valence behaviour.
Thoracoscopic resection of a giant leiomyoma of the esophagus with a mediastinal outgrowth.

K. Tamura,Shinzo Takamori,Kohsuke Tayama,M. Mitsuoka,A. Hayashi,Hiromasa Fujita,Kazuo Shirouzu

1998-12-01

Annals of Thoracic and Cardiovascular Surgery

Abstract:We reported a case of a 20-year-old man with a giant leiomyoma of the esophagus resected under video-assisted thoracic surgery (VATS). The patient demonstrated an abnormal shadow on a chest x-ray and a posterior mediastinal tumor 11 cm in diameter on a computed tomogram (CT) and on magnetic resonance imaging (MRI). A leiomyoma or a neurogenic tumor of the esophagus was suspected, and VATS was performed. The resected tumor was pathologically confirmed to be a leiomyoma of the esophagus. A giant esophageal leiomyoma showing extraluminal outgrowth should be treated by VATS.

Conservative hemodynamic surgery for varicose veins.

Field evaluation of validity and feasibility of Pan-Lassa rapid diagnostic test for Lassa fever in Abakaliki, Nigeria: a prospective diagnostic accuracy study

Lassa fever in Nigeria: epidemiology and risk perception

Seroprevalence and risk factors for Lassa virus infection in South-West and North-Central Nigeria: a community-based cross-sectional study

Differential pathogenesis of closely related 2018 Nigerian outbreak clade III Lassa virus isolates

MARINE ZOOLOGY IN THE HAWAIIAN ISLANDS.

Factors associated with delayed presentation to healthcare facilities for Lassa fever cases, Nigeria 2019: a retrospective cohort study

Ultrasound guided lithotripsy of salivary calculi using an electromagnetic lithotriptor.

Association of &bgr;-catenin with P-Smad3 but not LEF-1 dissociates in vitro profibrotic from anti-inflammatory effects of TGF-&bgr;1

Incorporating phosphorus cycling into global modeling efforts: a worthwhile, tractable endeavor.

Metagenomic surveillance uncovers diverse and novel viral taxa in febrile patients from Nigeria

Comparative Evaluation of Standard RT-PCR Assays and Commercial Real-Time RT-PCR Kits for Detection of Lassa Virus

Evaluation of Three Clinical Prediction Tools to Predict Mortality in Hospitalized Patients with Lassa Fever

Genome-wide association study identifies human genetic variants associated with fatal outcome from Lassa fever

Health and economic impacts of Lassa vaccination campaigns in West Africa

Machine Learning Reveals Key Glycoprotein Mutations and Rapidly Assigns Lassa Virus Lineages

The Importance of Lassa Fever and Its Disease Management in West Africa

An Assessment of Rainfall and Temperature on Seasonal Outbreak of Lassa Fever in Nigeria for the Year 2020

Lassa fever research priorities: towards effective medical countermeasures by the end of the decade

Highly-oxidised, sulfur-rich, mixed-valence vanadium(IV/V) complexes.

Thoracoscopic resection of a giant leiomyoma of the esophagus with a mediastinal outgrowth.